Is Corticophobia Spreading Among Pediatricians?-Insights from a Self-efficacy Survey on the Management of Pediatric Atopic Dermatitis
Overview
Affiliations
Background: Atopic dermatitis (AD) is a chronic dermatological condition, often diagnosed and managed by pediatricians. However, pediatricians have difficulties with adhering to guidelines, which recommend the use of topical corticosteroids (TCS) as a first-line treatment and oral corticosteroids (OCS) for resistant cases. Our aim was to assess pediatricians' self-confidence in using steroids in the management of pediatric AD, and investigate which characteristics are related to high self-confidence in prescribing corticosteroids (CS).
Methods: We conducted a cross-sectional questionnaire study among Israeli pediatricians between April 2022 and June 2022. Participants were asked to answer questions dealing with self-assessment of prescribing CS in the management of AD.
Results: A total of 171 residents and pediatricians participated in the survey; 86.6% and 28.1% admitted feeling either average or below-average confidence in the prescription of OCS and TCS, respectively. Physicians who were exposed to higher AD patients (P=0.048) and worked at the clinics (88.2% 60.4%, P<0.001) had high self-confidence in treating AD with TCS. Males (20.3% 8%, P=0.03), and having gone to medical school outside Israel (22.2% 10.4%, P=0.09) were all related to high self-efficacy in prescribing OCS. In total, 11.7% of participants confessed to refraining from prescribing steroids because of fear of side effects.
Conclusions: Most pediatricians have below-average confidence in prescribing OCS for the treatment of AD. Males, working in a community setting, and previous exposure improve the confidence level and can be easily considered in future pediatric training programs.
Medication adherence in allergic diseases and asthma: a literature review.
Malaya E, Piatkowska A, Panek M, Kuna P, Kupczyk M, Kardas G Front Pharmacol. 2024; 15:1488665.
PMID: 39687293 PMC: 11646763. DOI: 10.3389/fphar.2024.1488665.